The consequences of prenatal exposure to Cp-induced embryopathy are characterized by intrauterine growth restriction, developmental delays, a wide range of congenital malformations, and intrauterine death through oxidative stress and DNA damage [13,34]. The gene discussed is CP; the disease is fetal growth restriction.